Elliott RL, Suits JA, Yang DC, Jiang XP, Head JF. Increase in serum iron concentration after chemotherapy for breast cancer (abstract). Proceedings American Society of Clinical Oncology (NLMID: 830021). 1999 May; 18(1): 210.
Head JF, Jiang XP, Yang DC, Elliott RL. Serum interleukin 6 (IL-6) concentration correlates with serum tumor marker CA 15-3 concentration in breast cancer patients (abstract). Proceedings American Society of Clinical Oncology (NLMID: 830021). 1999 May; 18(1): 630.
Jiang X, Head JF, Yang DC, Elliott RL. Vaccination of breast cancer patients with autologous tumor-associated antigen results in reduction of serum interleukin 6 (abstract). Proceedings American Association for Cancer Research (NLMID: 0415753). 1998 Apr; 39(1): 356.
Jiang XP, Wang F, Head F, Yang DC. The deprivation of iron induces apoptosis in MCF-7 human breast cancer cell line and 13762 NF RAT mammary adenocarcinoma tumor (abstract). Breast Cancer Research and Treatment (NLMID: 8111104). 1997 Dec; 146(12): 1197.
Jiang XP, Wang F, Yang DC, Elliott RL, Head JF. Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo. Anticancer Res.. 2002 Sep; 22(5): 2685-2692. Cited in PubMed; PMID: 12529982.
Jiang XP, Yang DC, Elliott RL, Head JF. Reduction in serum IL-6 after vacination of breast cancer patients with tumour-associated antigens is related to estrogen receptor status. Cytokine.. 2000 May; 12(5): 458-465. Cited in PubMed; PMID: 10857759.
Jiang XP, Yang DC, Elliott RL, Head JF. Serum IL-6 reduction after vaccination of breast cancer patients with tumor-associated antiens is related to estrogen receptor status. J. Immunotherapy. 1999 Apr; 22(4): 459.
Jiang XP, Yang DC, Elliott RL, Head JF. Vaccination with a mixture of autologous and allogeneic breast cancer cells and the tumor associated antigens CA15-3, CEA and CA 125 results in immune and clinical response in breast cancer patients (abstract). Proceedings American Society of Clinical Oncology (NLMID: 830021). 2000 May; 19(1): 466.
Jiang XP, Yang DC, Elliott RL, Head JF. Serum interlukin-6 concentration is increased in postmenopausal and estrogen receptor negative breast cancer patients (abstract). Breast Cancer Research and Treatment (NLMID: 8111104). 1998 Sep; 50(1): 315.
Jiang XP, Yang DC, Elliott RL, Head JF.. Vaccination with a mixed vaccine of autogenous and allogeneic breast cancer cells and tumor associated antigens CA15-3, CEA and CA125–results in immune and clinical responses in breast cancer patients. Cancer Biother Radiopharm.. 2000 Oct; 15(5): 495-505. Cited in PubMed; PMID: 11155821.
Jiang XP, Yang DC, Head JF, Elliott RL. Interleukin-6 is a growth factor for human breast cancer cells. Breast Cancer Research and Treatment (NLMID: 8111104). 1999 Dec; 57(1): 117.
Jiang XP, Yang DC, Head JF, Elliott RL. Liposomal-mediated transfer of the human interleukin 6 gene into MCF-7 breast cancer cells results in increased synthesis of tumor associated antigen (abstract). Proceedings American Association for Cancer Research (NLMID: 0415753). 2001 Apr; 42(1): 820.
Jiang XP, Yang DC, Head JF, Elliott RL.. All-trans-retinoic acid down-regulates interleukin-6 synthesis in human breast cancer cells (abstract). Proceedings American Associatin for Cancer Research (NLMID: 0415753). 1999 Apr; 40(1): 63.
Lu YY, Zhang QY, Yang DC. Analysis of the relationship between aberrant structures and abnormal expression of P53 gene during gastric carcinogenesis and malignant features of tumor cells. Journal of Beijing Medical University. 1994 Jul; 26(7): 300. Cited in PubMed; PMID: (NLM ID: 9426451)..
Wang F, Jiang X, Yang DC, Elliott RL, Head JF. Doxorubicin-gallium-transferrin conjugate overcomes multidrug resistance: evidence for drug accumulation in the nucleus of drug resistant MCF-7/ADR cells. Anticancer Res.. 2000 Mar; 20(2A): 799-808. Cited in PubMed; PMID: 10810357.
Wang F, Jiang XP, Yang DC. Doxorubicin-gallium-transferrin conjugate overcoming multidrug resistance: evidence for nuclear drug accumulation in resistant cell MCF-7/ADR (abstract). Breast Cancer Research and Treatment (NLMID: 8111104). 1997 Dec; 146(1): 59.
Wang F, Jiang XP, Yang DC. Effects of gallium and gallium-transferrin on DNA synthesis, ferritin gene expressin and cellular ferritin synthesis in MCF-7 cells (abstract). Proceedings American Association for Cancer Research (NLMID: 0415753). 1997 Apr; 38(1): 601.
Wang LX, Yang DC, Lu YY, Takagi Y, Taira K, Li T, Zhang LH. The synthesis and biological activities of oligodeoxynucleotides that are covalently linked to psoralen at their 5′ ends. Drug Des Discov.,. 1995 Nov; 13(2): 109-121. Cited in PubMed; PMID: 8872455.
Xu WH, Bai JX, Yang DC. Relationship between deletions of nm23-H1 alleles and carcinogenesis of human colorectal carcinoma. Chinese Journal of Oncology. 1995 Jan; 17(7): 263-265. Cited in PubMed; PMID: NLMID: 7910681.
Xu WH, Yang DC. Point mutations of P53 gene in human colorectal carcinoma. Chinese Journal of Oncology. 1995 Dec; 17(12): 238-240. Cited in PubMed; PMID: NLMID: 7910681.
Xu WH, Yang DC. Loss of heterozygosity involving in APC tumor suppressor gene in human colorectal carcinoma. Chinese Journal of Cancer Research. 1995 Feb; 7(2): 51-54.
Yang DC, Bonilla M. Radiological evaluation and orthotic treatment in rheumatic foot diseases. Podiatric Medical Review.. 2004 Nov; 8(1): 58-61.
Yang DC, Chen YC. Diagnosis and treatment for the trauma of the human cardiac ventricle, case report. Journal of Nantong Medical College. 1989 Mar; 9(1): 233-235.
Yang DC, Elliott RL, Head JF.. Gene targets of antisense therapies in breast cancer, review. Expert Opin Ther Targets. 2002 Jun; 6(3): 375-385. Cited in PubMed; PMID: 12223074.
Yang DC, Elliott RL, Jiang XP, Head LF. Antisense-transferrin receptor gene inhibits growth of breast tumor cells (abstract). Breast Cancer Research and Treatment (NLMID: 8111104). 1999 Dec; 57(1): 54.
Yang DC, Geng ZJ. Clinical significance of C-Ha-Ras P21 expression in human gastric cancer. Chinese Journal of New Medicine. 1994 Jan; 4(1): 55-57.
Yang DC, Head JF, Hanks CP, Jiang CP, Elliott RL.. HER-2/NEU messenger RNA expression in human breast tumors has prognostic signifiance (abstract). Proceedings American Society of Clinical Oncology (NLMID: 830021). 2001 May; 20(1): 219.
Yang DC, Head JF, Jiag XP, Ferris J, Elliott RL. Growth inhibition of multidrug-sensitive and multidrug-resistant human breast cancer cell lines by gallium-transferrin (abstract). Proceedings American Association for Cancer Research (NLMID: 0415753). 1995 Apr; 39(1): 1760.
Yang DC, Head JF, Jiang XP, Elliott RL. Liposome mediate antisense ferritin light chain transfection inhibits proliferation of human breast cancer cells (abstract). Proceedings American Association for Cancer Research (NLMID: 0415753). 1999 Apr; 40(1): 478-479.
Yang DC, Head JF, Jiang XP, Elliott RL. Expression of cytokeratin 19 mRNA is associated with differentiation of human breast tumors (abstract). Proceedings American Society of Clinical Oncology (NLMID: 8300211). 1998 May; 17(1): 573.
Yang DC, Head JF, Jiang XP, Elliott RL. Reversal of multidrug resistance in the human breast cancer MCF-7/ADR cell line by gene targeted antisense oligonucleotides (abstract). Breast Cancer Research and Treatment (NLMID: 8111104). 1998 Dec; 50(1): 290.
Yang DC, Head JF, Jiang XP, Elliott RL.. Reversal of doxorubicin resistance by doxorubicin-gallium-transferrin conjugate in human breast cancer cell lines (abstract). Proceedings American Association for Cancer Research (NLMID: 0415753).. 1999 Apr; 40(1): 664.
Yang DC, Head JF, Jiang XP, Wang F, Elliiott RL. An antisense transferrin receptor oligonucleotide suppresses gene expression and proliferation in human breast cancer cell lines (abstract). Proceedings American Association for Cancer Research (NLMID: 0415753). 1998 Apr; 39(1): 417-418.
Yang DC, Head JF, Wang F, Elliott RL. Transferrin receptor mRNA and ferritin H-chain mRNA expression are associated with prognostic indicator for breast cancer (abstract). Proceedings American Association for Cancer Research (NLMID: 0415753). 1997 Apr; 38(1): 419-420.
Yang DC, Jiang X, Elliott RL, Head JF. Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells. Anticancer Res.. 2002 May; 22(3): 1513-1524. Cited in PubMed; PMID: 12168831.
Yang DC, Jiang XP, Elliott RL, Head JF. Synergistic inhibition of breast carcinoma cell growth by combinations of HER-2/Neu antisense DNA and chemotherapeutic agents (abstract). Proceedings American Association for Cancer Research (NLMID: 0415153). 2001 Apr; 42(1): 729.
Yang DC, Jiang XP, Elliott RL, Head JF. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene. Anticancer Res.. 2001 May; 21(3B): 1777-1787. Cited in PubMed; PMID: 11497259.
Yang DC, Jiang XP, Elliott RL, Head JF. Antisense transferrin receptor oligonucleotide induces apoptosis in human MCF-7 breast carcinoma cells (abstract). Proceedings American Association for Cancer Research (NLMID: 0415753). 2000 Apr; 41(1): 752.
Yang DC, Jiang XP, Head JF, Elliott RL. Clinical significance of MDR1 and MRP gene expression in primary breast tumor (abstract). Proceedings American Society of Clinical Oncology (NLMID: 830021). 2000 May; 19(1): 214.
Yang DC, Jiang XP, Head JF, Elliott RL. Synergistic inhibition of breast tumor MCF-7 cells growth by combinations of transferrin receptor antisense DNA, deferoxamine and hydroxyurea (abstract). Proceedings American Association for Cancer Research (NLMID: 0415753). 2000 Apr; 41(1): 644.
Yang DC, LI T, Lu YY. The hypomethylation of C-Ha-Ras gene in human gastric tumorigenesis. Journal of Beijing Medical University. 1994 Mar; 26(3): 102-104. Cited in PubMed; PMID: NLM ID: 9426451.
Yang DC, LI T, Lu YY.. The study of the loss of loci on chromosome 8 in the human gastric carcinoma. Chinese Journal of Experimental Surgery. 1994 Apr; 11(4): 148-149. Cited in PubMed; PMID: (NLMID: 9426419).
Yang DC, LI T, Zhang LH. Specific inhibitions of C-Ha-Ras expression and the tumorigenicity of transformed Cells by Antisense DNAs and its psoralen derivatives. Proceedings International Cancer Congress (New Delhi, India). 1994 Sep; 16(1): 227-2336.
Yang DC, Li T. Alterations of the tumor suppressor genes in human lung cancer, review. Chinese Journal of Cancer. 1994 May; 13(5): 195-197. Cited in PubMed; PMID: NLMID: 9424852.
Yang DC, Li T. Interstitial therapy in human hepatocellular carcinoma, review. Chinese Journal of Clinical Oncology… 1994 Oct; 21(10): 462-464.
Yang DC, Li T. Ras gene mutations and carcinogenesis, review. Chinese Journal of Clinical Cancer. 1992 Mar; 7(3): 221-226.
Yang DC, Li T. Scientific thought process in the study of oncogenes and tumor metastasis. Chinese Journal of Medicine and Philosophy. 1992 Jan; 13(1): 7-8.
Yang DC, Li T, Xu WH. Correlatin of overexpression of C-Ha-Ras mRNA with the clinical manifestation in patients with stomach cancer. Chinese Journal of Clinical Oncology. 1995 May; 22(5): 164-167.
Yang DC, Li T, Xu WH. Inhibition of antisense C-Ha-Ras DNA and its derivative on carcinogenesis of gastric transformed cells. Chinese Journal of Surgery. 1995 Jan; 33(1): 26-28. Cited in PubMed; PMID: NLMID: 0153611.
Yang DC, Li T, Xu WH. P53 gene deletion and abnormal expression in gastric carcinoma. 1995, May; 17(5):175-178. Pub Status: Published.. Chinese Journal of Oncology. 1995 May; 17(5): 175-178. Cited in PubMed; PMID: NLMID: 7910681.
Yang DC, Li T, Xu WH. Relationship between overexpression of C-Ha-Ras mRNA and metastatic status in gastric cancer patients. Chinese Journal of Experimental Surgery. 1994 Feb; 11(2 (suppl)): 93-94. Cited in PubMed; PMID: NLMID: 9426419.
Yang DC, Li T, Xu WH. Detection and clinical significance of C-Ha-Ras gene mutations in primary gastric cancer. Chinese Journal of Experimental Surgery.. 1994 Feb; 11(2 (suppl)): 95-96.
Yang DC, Wang F, Elliott RL, Head JF. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer. Anticancer Res.. 2001 Jan; 21(1B): 541-549. Cited in PubMed; PMID: 11299801.
Yang DC, Xu WH, Li T. Study on the clinical significance of the loci LOH on chromosomal 8 in human gastric carcinomas. Chinese Journal of Clinical Oncology. 1995 Mar; 22(3): 98-100.
Yang DC, Xu WH, Li T. Effect of NB 901 on DNA topoisomerase II activity and C-Ha-Ras gene expression in human gastric cells. Chinese Journal of Cancer. 1994 May; 11(4): 148-149. Cited in PubMed; PMID: NLMID: 9424852.
Yang DC, Xu WH, Lu YY. Establishment and clinical applications of the C-Ha-Ras gene mutation analysis methods in gastric cancer. Chinese Journal of Cancer Prevention and Treatment. 1995 Jan; 22(1): 5-8. Cited in PubMed; PMID: NLMID: 101179889.
Yang DC, Zhan HS, Zhang LH, Li T. Reversion of malignant phenotypes of the transformed cells by C-Ha-Ras antisense DNA. Journal of Beijing Medical University. 1995 Nov; 27(11): 353-355. Cited in PubMed; PMID: NLM ID: 9426451.
Yang DC, Zhy YQ. Detection of C-Ha-Ras gene mutations using direct sequence of polymerase chain reaction product. Chinese Journal of New Medicine.. 1994 Mar; 4(3): 97-98.
POSTER PRESENTATION:
Jiang XP, Yang DC, Elliott RL, Head JF. (. (2000, September). Inteleukin 6 increases the antigen expression of MCF-7 breast cancer cells. Poster presented at: 2nd Annual Lynn Sage Breast Cancer Symposium in Conjuction with the Annual Meeting of the American Society of Breast Diseases; Chicago, IL.
Yang DC, Faroqi L. (2009, September). Demagraft promotes chronic diabetic wound healing. Poster presented at: Diabetic Limb Salvage Conference; Washington DC, DC.
Yang DC, Head JF, Jiang XP, Elliott RL.. (2000, September). The inhibition of MCF-7 breast carcinoma cell growth by antisense oligonucleotides targeted against ferritin genes. Poster presented at: 2nd Annual Lynn Sage Breast Cancer Symposium in Conjunction with the Annual Meeting of the American Society of Breast Disease; Chicago, IL.